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SUMMARY: 
The discovery of the tetrahydro-1H-[3]-benzazepine SCH23390 [1], represented one of the most 
important advances in the study of dopaminergic receptors due to their behavior as a selective D1 
receptor antagonist. The high affinity and selectivity of this tetrahydro-1H-[3]-benzazepine has led to 
the search for new structures because of their potential dopaminergic activity, especially 1-aryl-
substituted tetrahydro-1H-[3]-benzazepines. Furthermore, their precursors, the tetrahydroisoquinolines 
1-substituted have shown to have activity for D1 and D2 dopaminergic receptors.[2] 
 
We have carried out the synthesis of tetrahydro-1H-[3]-benzazepines 1,2-di-substituted by Stevens 
rearrangement (SR) on tetrahydroisoquinolinium salts. Stevens rearrangement is an efficient regio- and 
diastereoselective synthetic methodology. [3a,b] As part of our studies, we have performed the synthesis 
of benzazepines with modifications at the C-1 and C-2 positions with chlorine and hydroxyl groups at 
A-ring which is an important factor to modulate affinity at dopaminergic receptors. 
 
The interaction of these molecules with D1 and D2 dopaminergic receptors have been studied to 
establish a structure-activity relationship by radioligand binding assays. 
 
[1] a) Bourne, J. A., CNS Drug Review 2001, 7, 399–414. b) Gold, E. H.; Chang, W. K., U. S. Patent 
4284555, 1981. 
[2] Suvire, F. D.; Andreu, I; Bermejo, A.; Zamora, M. A.; Cortes, D.; Enriz, R. D., J. Mol. Struc. 
TEOCHEM 666-667 2003, 109-116. 
[3] a) Valpuesta, M.; Ariza, M.; Díaz, A.; Suau, R. Eur. J. Org. Chem. 2010, 23, 4393-4401. b) Ariza, 
M.; Díaz, A.; Suau, R.; Valpuesta, M. Eur. J. Org. Chem. 2011, 32, 6507-6518. 
 
